To further evaluate the clinical significance of HMGA1 in breast cancer, we combined microarray analyses with clinical information regarding primary breast tumours and found that HMGA1 regulates a set of genes that may potentially be used as an independent predictor of poor clinical outcomes in breast cancer. This evidence concerns the gene HMGA1 and breast cancer.